About
Molecular Diagnostics
Areas of Focus
Categories
DiagnosticsNon-PharmaceuticalMountain West
Clinical Trials (17)
View allTotal Trials
17
As Lead Sponsor
0
As Collaborator
17
Total Enrollment
5,543
By Phase
PHASE2: 4PHASE4: 1PHASE1: 2NA: 2PHASE3: 5PHASE1/PHASE2: 1
By Status
COMPLETED: 11ACTIVE_NOT_RECRUITING: 4RECRUITING: 1TERMINATED: 1
Clinical Trials Pipeline17 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT05642780Collaborator
SKB264 in Combination With Pembrolizumab in Subjects With Selected Solid Tumors
PHASE2Active, not recruiting
240 participants
Started: Jan 17, 2023 · Completed: Dec 31, 2027
NCT05457257Collaborator
Clinical Study to Assess the Efficacy and Safety of Olaparib in Chinese Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Failed Prior Treatment With a New Hormonal Agent and Have BRCA1/2 Mutations
PHASE4Active, not recruiting
43 participants
Started: Jul 29, 2022 · Completed: Sep 30, 2025
NCT04150042Collaborator
SHARON: A Clinical Trial for Metastatic Cancer With a BRCA or PALB2 Mutation Using Chemotherapy and Patients' Own Stem Cells
PHASE1Recruiting
10 participants
Started: Jan 13, 2021 · Completed: Aug 31, 2027
NCT04245176Collaborator
Genetic Testing for All Breast Cancer Patients (GET FACTS)
NAActive, not recruiting
400 participants
Started: Jan 31, 2020 · Completed: Dec 1, 2025
NCT03402841Collaborator
Multicentre Study of Olaparib Maintenance Monotherapy in Platinum Sensitive Relapsed Non gBRCAm Ovarian Cancer Patients
PHASE3Completed
279 participants
Started: Jan 30, 2018 · Completed: Mar 10, 2022
Locations (1)
Headquarters
Salt Lake City, UT, United States
Map
Loading map...